Biodexa Pharmaceuticals (MTPH) News Today → Urgent Nvidia Warning (From Altimetry) (Ad) Free MTPH Stock Alerts GBX 18 -1.00 (-5.26%) (As of 03/27/2023) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBiodexa Pharmaceuticals (LON:MTPH) Stock Passes Above 50-Day Moving Average of $18.00americanbankingnews.com - May 4 at 5:22 AMBiodexa shares rally 126% on rapamycin licensing dealseekingalpha.com - April 26 at 6:03 PMBiodexa Pharmaceuticals (LON:MTPH) Stock Price Passes Above 50-Day Moving Average of $18.00americanbankingnews.com - April 25 at 4:16 AMSLRX Salarius Pharmaceuticals, Inc.seekingalpha.com - March 28 at 11:26 PMBiodexa stock slides 7% amid data for two drug studiesmsn.com - February 23 at 2:55 PMBiodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patientsmarkets.businessinsider.com - February 8 at 12:45 PMBiodexa stock jumps on allowance of U.S. patent covering Tolimidonemsn.com - February 7 at 10:07 AMBiodexa Announces Allowance of U.S. Patent Covering Tolimidonetmcnet.com - February 7 at 10:07 AMBiodexa Pharmaceuticals down 21%, prices equity offeringmsn.com - December 19 at 3:02 PMWhat's Going On With Biodexa Pharmaceuticals Stock (BDRX) Today?msn.com - November 28 at 12:27 PMBiodexa Enters Worldwide Licensing Deal for Tolimidonemarketwatch.com - November 27 at 4:24 PMBiodexa jumps on licensing deal for diabetes candidatemsn.com - November 27 at 4:24 PMBiodexa Pharma Shares Double After Licensing Deal for Tolimidonemarketwatch.com - November 27 at 11:23 AMBiodexa Pharmaceuticals Plc ADR BDRXmorningstar.com - November 19 at 1:56 PMBiodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastomatmcnet.com - October 3 at 1:04 PMBiodexa Pharmaceuticals announces ADR ratio changemsn.com - June 23 at 7:29 AMBiodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticalstechnews.tmcnet.com - May 18 at 10:32 AMBiodexa Pharmaceuticals PLC DRC (BDRX)investing.com - April 22 at 8:07 PMBiodexa Pharmaceuticals PLC Announces Issue of Pre-Funded Warrantsfinance.yahoo.com - April 3 at 8:31 AMBiodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equityfinance.yahoo.com - March 28 at 5:44 PMMidatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Diseasefinance.yahoo.com - March 27 at 10:18 AMMidatech Pharma PLC Announces Results of General Meetingfinance.yahoo.com - March 24 at 8:38 AMMidatech Pharma PLC Announces Further re: Notice of General Meetingfinance.yahoo.com - March 10 at 4:06 PMMidatech Pharma PLC Announces Closing of $6.0m Private Placement & Broker Changefinance.yahoo.com - February 15 at 7:00 AMMidatech Pharma to Raise About $6 Million to Develop Cancer Treatmentmarketwatch.com - February 9 at 3:46 PMMidatech Pharma PLC Announces Posting of Circular and Notice of General Meetingfinance.yahoo.com - January 6 at 7:32 AMBioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plcfinance.yahoo.com - December 19 at 8:10 AMMidatech Pharma PLC Announces Closing of Offering, Revised Terms, AIM & Webinarfinance.yahoo.com - December 19 at 3:09 AMMidatech Pharma PLC - First Patient Enrolled in Phase 1 Study of MTX-110finance.yahoo.com - November 14 at 2:34 AMMidatech Pharma PLC Announces Receipt of NASDAQ Notificationfinance.yahoo.com - October 18 at 3:32 AMMidatech Pharma PLC Announces Interim Results for the Six Months to 30 June 2022finance.yahoo.com - September 14 at 3:58 AMMidatech Pharma PLC Announces Directorate Changefinanznachrichten.de - June 20 at 2:12 PMMidatech Pharma's Shares Shoot Higher On FDA Fast Track Designation For Malignant Brain Tumor Drugmsn.com - June 1 at 6:42 PMMidatech Pharma Shares Rise on FDA Fast Track Designation for Cancer Treatmentmarketwatch.com - June 1 at 8:13 AMMidatech Pharma PLC Announces Fast Track Designation for MTX110 Developmentfinance.yahoo.com - June 1 at 8:13 AMMidatech Pharma PLC Announces Results for the Year Ended 31 December 2021finance.yahoo.com - April 26 at 3:18 AMMidatech Pharma PLC Announces R&D Collaboration with Janssen on Second Moleculefinance.yahoo.com - March 9 at 8:01 AMMidatech Pharma PLC : Midatech presenting at the Shares/AJ Bell Webinarmarkets.businessinsider.com - November 25 at 8:18 AMIs Midatech Pharma (LON:MTPH) In A Good Position To Invest In Growth?finance.yahoo.com - November 13 at 7:42 AMMidatech Pharma 1H Loss Narrowed Sharplymarketwatch.com - September 17 at 12:55 PM Get Biodexa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MTPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. MTPH Media Mentions By Week MTPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MTPH News Sentiment▼0.590.42▲Average Medical News Sentiment MTPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MTPH Articles This Week▼10▲MTPH Articles Average Week Get Biodexa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MTPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: REDX News OKYO News C4XD News SAR News HEMO News DEST News AREC News OBD News ONC News OPTI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:MTPH) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
